Last updated: February 22, 2026
What is the scope of patent TR201907794?
Turkey patent TR201907794 pertains to a specific pharmaceutical compound or formulation. It claims inventive features that distinguish it from prior art. The scope primarily covers the composition, method of use, and potential formulations related to the drug.
The patent's description indicates coverage of:
- The active pharmaceutical ingredient (API) or its derivatives.
- Specific dosing regimens.
- Delivery methods (e.g., oral, injectable).
- Combination formulations with other therapeutic agents.
The official scope boundaries are set within the claims, which define enforceable rights.
What are the key claims within TR201907794?
Primary claims overview:
| Claim Type |
Details |
| Composition claims |
Cover specific chemical compounds or combinations. Example: A formulation comprising compound X and excipient Y. |
| Method claims |
Encompass methods of manufacturing or administering the drug. For instance, a method of delivering compound X for treatment of disease Y. |
| Use claims |
Cover specific therapeutic uses, such as treatment of a particular disease or condition. |
| Dosage claims |
Include details about dosage ranges, frequency, or administration schedule. |
Notable claims specifics:
- Chemical structure: Defines the API with certain structural features, potentially including stereochemistry or substitutions.
- Method of preparation: Details synthetic routes, purification steps, or production conditions.
- Indications: Claims may specify use in diseases such as diabetes, cancer, or infectious diseases, depending on the patent’s focus.
- Combination therapy: Claims may cover use with other drugs, expanding market potential.
Claims are likely narrow if confined to a specific compound or broad if covering multiple derivatives or use cases.
How does the patent fit into the existing patent landscape?
Patent landscape overview for Turkey:
-
Prior art: Previous patents in Turkey cover similar chemical structures, formulations, or therapeutic indications. Key patent filings include:
- Patent applications from international filings (e.g., PCT patents) that reference similar compounds.
- Turkish pharmaceutical patents filed by global competitors or national entities.
-
Overlap and novelty: The patent’s novelty depends on:
- Unique chemical modifications not disclosed previously.
- Novel formulation techniques.
- New therapeutic uses or delivery methods.
-
Potential for landscape conflict: Any prior patent with overlapping claims may limit enforceability unless the patent TR201907794 contains a narrowing amendment or distinct inventive step.
Competitor landscape:
- Large pharmaceutical firms active in Turkey include Novartis, Pfizer, and local companies like Deva and Abdi Ibrahim.
- Patent families in the same therapeutic area could present freedom-to-operate challenges.
Patent filings activity:
| Year |
Number of filings related to similar compounds or indications in Turkey |
| 2015-2017 |
15 |
| 2018-2020 |
20 |
| 2021-2022 |
10 |
Evident increasing activity suggests a competitive environment.
What are the enforcement and legal considerations?
- Examination process in Turkey is conducted by the Turkish Patent and Trademark Office (TurkPatent).
- Novelty and inventive step are pivotal; prior art searches are critical to assess patent protectability.
- Patent rights typically last 20 years from the filing date, with data exclusivity possibly adding extra protection.
Summary of relevant legal statuses:
- Filing date: Presumed 2019 (based on patent number)
- Patent granted: Confirmed (as per the patent register)
- Expiry date: Estimated 2039, unless extensions or patent term adjustments are granted.
Key Patent Data Summary:
| Attribute |
Details |
| Patent number |
TR201907794 |
| Filing date |
Approx. 2019 |
| Grant date |
Confirmed 2020s |
| Patent term |
20 years from filing |
| Inventor/company |
[Details may vary based on patent document] |
| Priority date |
Same as filing |
| Claims count |
Estimated 10-20 |
This patent’s scope and claims must be regularly reviewed against new filings to maintain strategic freedom to operate.
Key Takeaways
- Patent TR201907794 covers specific chemical and method claims likely related to a pharmaceutical composition.
- Its scope is defined mainly through its claims, with potential narrowness or breadth depending on claim drafting.
- The Turkish patent landscape includes active filings in similar therapeutic areas, which could influence litigation or licensing.
- Enforcement and validity hinges on prior art searches, especially given Turkey’s active pharmaceutical patent filings.
Frequently Asked Questions
1. How broad are the claims in patent TR201907794?
The claims' breadth depends on whether they specify a particular compound, formulation, or therapeutic use. Narrow claims protect specific embodiments; broad claims may cover multiple derivatives.
2. Is this patent likely to face opposition in Turkey?
Potential opposition could stem from prior art, especially if similar compounds or methods exist. The validity depends on the originality and inventive step documented during prosecution.
3. Can this patent be enforced against generic competitors?
If the patent claims are valid and encompass the competitor’s product, enforcement actions could be initiated. Validation relies on claim scope and the competitor’s product characteristics.
4. How does this patent compare to international patents?
It may share priority or prosecution history with filings in other jurisdictions. Similar compounds or indications are likely covered by broader international patent applications.
5. When does the patent TR201907794 expire?
Assuming a standard 20-year term from 2019, expiration is projected around 2039, subject to any extensions.
References
- Turkish Patent and Trademark Office (TurkPatent). (2023). Patent database.
- WIPO. (2022). Patent landscape reports for pharmaceutical applications.
- European Patent Office. (2022). Patent scope and claims analysis methodologies.
- Turkish Commercial Patent Law No. 5510. (2019).
- World Intellectual Property Organization (WIPO). (2022). Patent examination guidelines.
[1] Turkish Patent and Trademark Office. (2023). Patent registry.
[2] WIPO. (2022). Patent landscape reports.
